Pharmaceuticals, Biotechnology & Life Sciences

Ibio shares tumble 7.7%—now at $0.71—after a 40% drop this month. With a $46M cap and 52‑week low at $0.71, investors eye potential rebound.

See why Alembic stock fell 3.93% today, its 24‑hr trading volume, market cap, and key price levels, and compare the move to peers like Axis, Bls E‑Services, and Kernex.

Cel‑Sci stock rises 1.86% to $1.59, trading 68.7k shares amid biotech growth prospects and recent 52‑week highs at $9.28.

Sab Biotherapeutics shares fell 6.58% to $2.79, down 15% YTD. Market cap $258M, 52‑week high $5.15. Explore real-time price, trend, and investment insights.

IQVIA (IQV) stock up 0.37% amid a strong 52‑week high of $282.98—discover how its $46 bn market cap, 200‑day SMA, and sector peers could impact your portfolio.

Discover how Bicycle Therapeutics (BCYC) is trading at $3.65, its $248 m market cap, and 52‑week highs/lows—gain insights into a biotech firm blending small‑molecule and biopharma innovation.

Racura Oncology stock: AUD 1.64, 24‑hr trade $96k, 52‑week high $3.79. Learn its 200‑day SMA, market cap, and recent performance trends for informed investment decisions.

Explore Larimar Therapeutics (LRMR) stock performance, market cap, and rare‑disease biotech insights—stay ahead of the 2026 market trends.

Exicure (XCUR) dips 7% as traders weigh its $1.09 price, $6.9M cap and 52‑week high of $9.48—discover why investors pause on this biotech stock.

Brooks Laboratories stock dips 5.29%, now at ₹57.86. Market cap ₹1.7 bn, 52‑week high ₹116, low ₹36.3—see latest 24‑h market trend.